$3.60
0.061.69%
After Hours: Jul 19, 6:03 PM EDT
15 minutes delayed
Comments
Loading...
Dare Bioscience
DARENASDAQ
Unlock major analysts' bullish and bearish positions by joining Benzinga Edge.
Dare Bioscience (NASDAQ:DARE) Stock, Analyst Ratings, Price Targets, Forecasts
Dare Bioscience Inc has a consensus price target of $5 based on the ratings of 3 analysts. The high is $6 issued by HC Wainwright & Co. on May 15, 2024. The low is $3 issued by Brookline Capital on May 15, 2024. The 3 most-recent analyst ratings were released by HC Wainwright & Co., Brookline Capital, and HC Wainwright & Co. on May 15, 2024, May 15, 2024, and May 1, 2024, respectively. With an average price target of $5 between HC Wainwright & Co., Brookline Capital, and HC Wainwright & Co., there's an implied 36.24% upside for Dare Bioscience Inc from these most-recent analyst ratings.
Analyst Firms Making Recommendations1
HC Wainwright & Co.
Brookline Capital
JonesTrading
1calculated from analyst ratings
Analyst Ratings for Dare Bioscience
| Buy Now | Get Alert | |||||||
|---|---|---|---|---|---|---|---|---|
| 05/15/2024 | Buy Now | 63.49% | HC Wainwright & Co. | Douglas Tsao | $72 → $72 | Reiterates | Buy → Buy | Get Alert |
| 05/15/2024 | Buy Now | -18.26% | Brookline Capital | Kemp Dolliver | → $36 | Upgrade | Hold → Buy | Get Alert |
| 05/01/2024 | Buy Now | 63.49% | HC Wainwright & Co. | Douglas Tsao | $72 → $72 | Reiterates | Buy → Buy | Get Alert |
| 04/17/2024 | Buy Now | — | Brookline Capital | Kemp Dolliver | — | Downgrade | Buy → Hold | Get Alert |
| 04/01/2024 | Buy Now | 63.49% | HC Wainwright & Co. | Douglas Tsao | → $72 | Reiterates | Buy → Buy | Get Alert |
| 11/10/2023 | Buy Now | 63.49% | HC Wainwright & Co. | Douglas Tsao | $84 → $72 | Maintains | Buy | Get Alert |
| 08/11/2023 | Buy Now | 90.74% | HC Wainwright & Co. | Douglas Tsao | → $84 | Reiterates | Buy → Buy | Get Alert |
| 07/13/2023 | Buy Now | 90.74% | HC Wainwright & Co. | Douglas Tsao | → $84 | Reiterates | Buy → Buy | Get Alert |
| 06/06/2023 | Buy Now | 90.74% | HC Wainwright & Co. | Douglas Tsao | → $84 | Reiterates | → Buy | Get Alert |
| 05/22/2023 | Buy Now | 90.74% | HC Wainwright & Co. | Douglas Tsao | → $84 | Reiterates | Buy → Buy | Get Alert |
| 05/12/2023 | Buy Now | 90.74% | HC Wainwright & Co. | Douglas Tsao | → $84 | Reiterates | Buy → Buy | Get Alert |
| 03/31/2023 | Buy Now | 90.74% | HC Wainwright & Co. | Douglas Tsao | → $84 | Reiterates | → Buy | Get Alert |
| 12/13/2022 | Buy Now | 90.74% | HC Wainwright & Co. | Douglas Tsao | $72 → $84 | Maintains | Buy | Get Alert |
| 12/01/2022 | Buy Now | 63.49% | JonesTrading | Catherine Novack | → $72 | Initiates | → Buy | Get Alert |
| 04/01/2022 | Buy Now | 63.49% | HC Wainwright & Co. | Douglas Tsao | $60 → $72 | Maintains | Buy | Get Alert |
FAQ
What is the target price for Dare Bioscience (DARE) stock?
The latest price target for Dare Bioscience (NASDAQ:DARE) was reported by HC Wainwright & Co. on May 15, 2024. The analyst firm set a price target for $6.00 expecting DARE to rise to within 12 months (a possible 66.67% upside). 7 analyst firms have reported ratings in the last year.
What is the most recent analyst rating for Dare Bioscience (DARE)?
The latest analyst rating for Dare Bioscience (NASDAQ:DARE) was provided by HC Wainwright & Co., and Dare Bioscience reiterated their buy rating.
When was the last upgrade for Dare Bioscience (DARE)?
The last upgrade for Dare Bioscience Inc happened on May 15, 2024 when Brookline Capital raised their price target to $3. Brookline Capital previously had a hold for Dare Bioscience Inc.
When was the last downgrade for Dare Bioscience (DARE)?
The last downgrade for Dare Bioscience Inc happened on April 17, 2024 when Brookline Capital changed their price target from N/A to N/A for Dare Bioscience Inc.
When is the next analyst rating going to be posted or updated for Dare Bioscience (DARE)?
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Dare Bioscience, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Dare Bioscience was filed on May 15, 2024 so you should expect the next rating to be made available sometime around May 15, 2025.
Is the Analyst Rating Dare Bioscience (DARE) correct?
While ratings are subjective and will change, the latest Dare Bioscience (DARE) rating was a reiterated with a price target of $6.00 to $6.00. The current price Dare Bioscience (DARE) is trading at is $3.60, which is out of the analyst’s predicted range.
Browse analyst ratings and price targets on all stocks.